Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-082031
Filing Date
2017-03-14
Accepted
2017-03-14 16:09:33
Documents
72
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d331243d10k.htm 10-K 1254040
2 EX-10.27 d331243dex1027.htm EX-10.27 14157
3 EX-23.1 d331243dex231.htm EX-23.1 2352
4 EX-23.2 d331243dex232.htm EX-23.2 2042
5 EX-31.1 d331243dex311.htm EX-31.1 9544
6 EX-31.2 d331243dex312.htm EX-31.2 9522
7 EX-32.1 d331243dex321.htm EX-32.1 4762
14 GRAPHIC g331243dsp058.jpg GRAPHIC 59194
  Complete submission text file 0001193125-17-082031.txt   4933656

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT rxdx-20161231.xml EX-101.INS 726941
9 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20161231.xsd EX-101.SCH 46401
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxdx-20161231_cal.xml EX-101.CAL 73956
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxdx-20161231_def.xml EX-101.DEF 164476
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20161231_lab.xml EX-101.LAB 446019
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20161231_pre.xml EX-101.PRE 314480
Mailing Address 4545 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4545 TOWNE CENTRE COURT SAN DIEGO CA 92121 (858) 255-5959
Ignyta, Inc. (Filer) CIK: 0001557421 (see all company filings)

EIN.: 453174872 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36344 | Film No.: 17688147
SIC: 2834 Pharmaceutical Preparations